Lydia B. Hörndler Gil

Lydia B. Hörndler Gil obtained her BSc in Veterinary Medicine from the University of Zaragoza (Spain), where she also completed MSc degrees in Food Safety and Biotechnology and in Biophysics and Quantitative Biotechnology. She earned her PhD in Molecular Biology from the Autonomous University of Madrid (Spain), where her research focused on the development of combinatorial CAR-T cell therapies for acute myeloid leukemia to overcome on-target off-tumor toxicity. During her doctoral and postdoctoral research at the Centro de Biología Molecular Severo Ochoa (Madrid), she specialized in immunotherapy and T-cell signaling, and was awarded an EMBO short-term fellowship to conduct research at the University of Freiburg (Germany). She currently works as teaching staff at Universidad San Jorge and as a researcher at the University of Zaragoza, focusing on cancer immunotherapy and translational immunology.